| Overview of neutralizing antibodies and their potential in COVID-19 JJ Morales-Núñez, JF Muñoz-Valle, PC Torres-Hernández, ... Vaccines 9 (12), 1376, 2021 | 68 | 2021 |
| Neutralizing antibodies titers and side effects in response to BNT162b2 vaccine in healthcare workers with and without prior SARS-CoV-2 infection JJ Morales-Núñez, JF Muñoz-Valle, C Meza-López, LF Wang, ... Vaccines 9 (7), 742, 2021 | 47 | 2021 |
| Neutralizing antibodies against SARS-CoV-2, anti-Ad5 antibodies, and reactogenicity in response to Ad5-nCoV (CanSino Biologics) vaccine in individuals with and without prior … J Hernandez-Bello, JJ Morales-Núñez, AC Machado-Sulbarán, ... Vaccines 9 (9), 1047, 2021 | 34 | 2021 |
| Metabolic syndrome in rheumatoid arthritis patients: Relationship among its clinical components M García‐Chagollán, SE Hernández‐Martínez, AE Rojas‐Romero, ... Journal of Clinical Laboratory Analysis 35 (3), e23666, 2021 | 17 | 2021 |
| de la O-Gómez, B JJ Morales-Núñez, JF Muñoz-Valle, C Meza-López, LF Wang, ... Balcázar-Félix, P, 0 | 16 | |
| de la O-Gómez, B.; Balcázar-Félix, P.; Hernández-Bello, J. Neutralizing antibodies titers and side effects in response to BNT162b2 vaccine in healthcare workers with and … JJ Morales-Núñez, JF Muñoz-Valle, C Meza-López, LF Wang, ... Vaccines (Basel) 9 (7), 742, 2021 | 15 | 2021 |
| Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing … JJ Morales-Núñez, JF Muñoz-Valle, AC Machado-Sulbarán, ... Immunology Letters 251, 20-28, 2022 | 13 | 2022 |
| Differences in B-cell immunophenotypes and neutralizing antibodies against SARS-coV-2 after administration of BNT162b2 (Pfizer-bioNTech) vaccine in individuals with and without … JJ Morales-Núñez, M García-Chagollán, JF Muñoz-Valle, SA Díaz-Pérez, ... Journal of Inflammation Research, 4449-4466, 2022 | 8 | 2022 |
| Overview of Neutralizing Antibodies and Their Potential in COVID-19. Vaccines 2021, 9, 1376 JJ Morales-Núñez, JF Muñoz-Valle, PC Torres-Hernández, ... | 6 | 2021 |
| Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment JJ Morales-Núñez, JF Muñoz-Valle, M García-Chagollán, S Cerpa-Cruz, ... Clinical and Experimental Immunology 214 (3), 314-327, 2023 | 3 | 2023 |
| BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study J Hernández-Bello, JJ Sierra-García-de-Quevedo, JJ Morales-Núñez, ... Vaccines 11 (6), 1127, 2023 | 1 | 2023 |
| Comments on “Single nucleotide polymorphism of Methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis” O Íñiguez-Mosqueda, LL Peña-Rodríguez, IV Reyes-Pérez, ... Clinical Rheumatology 43 (12), 4017-4017, 2024 | | 2024 |
| Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the-675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population JA Lomelí-Nieto, JF Muñoz-Valle, JE Navarro-Zarza, ... Life 14 (9), 1056, 2024 | | 2024 |
| Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population J Hernández-Bello, AC Lorenzo-Leal, JF Muñoz-Valle, JJ Morales-Núñez, ... Plos one 19 (4), e0299520, 2024 | | 2024 |
| Jorge Hernández-Bello Overview of Neutralizing Antibodies and Their Potential in COVID-19. Vaccines 2021, 9, 1376 JJ Morales-Núñez, JF Muñoz-Valle s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2021 | | 2021 |
